Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
92.73
-5.34 (-5.45%)
At close: Feb 27, 2026, 4:00 PM EST
92.66
-0.07 (-0.08%)
After-hours: Feb 27, 2026, 7:32 PM EST
Rhythm Pharmaceuticals Stock Forecast
Stock Price Forecast
The 14 analysts that cover Rhythm Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $130.57, which forecasts a 40.81% increase in the stock price over the next year. The lowest target is $94 and the highest is $176.
Price Target: $130.57 (+40.81%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Rhythm Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 8 | 8 |
| Buy | 5 | 5 | 5 | 5 | 5 | 6 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 13 | 13 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $145 → $136 | Buy | Maintains | $145 → $136 | +46.66% | Feb 27, 2026 |
| Citizens | Citizens | Buy Maintains $167 → $176 | Buy | Maintains | $167 → $176 | +89.80% | Feb 27, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $140 → $143 | Strong Buy | Maintains | $140 → $143 | +54.21% | Feb 27, 2026 |
| Needham | Needham | Strong Buy Maintains $148 → $139 | Strong Buy | Maintains | $148 → $139 | +49.90% | Feb 26, 2026 |
| RBC Capital | RBC Capital | Buy Initiates $145 | Buy | Initiates | $145 | +56.37% | Feb 19, 2026 |
Financial Forecast
Revenue This Year
300.53M
from 189.76M
Increased by 58.38%
Revenue Next Year
552.83M
from 300.53M
Increased by 83.95%
EPS This Year
-2.75
from -3.11
EPS Next Year
0.43
from -2.75
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 347.0M | 709.9M | |||
| Avg | 300.5M | 552.8M | |||
| Low | 257.6M | 436.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 82.9% | 136.2% | |||
| Avg | 58.4% | 84.0% | |||
| Low | 35.8% | 45.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -2.08 | 2.13 | |||
| Avg | -2.75 | 0.43 | |||
| Low | -3.58 | -1.03 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.